The Team

An experienced team of ambitious experts in the field.

Abraham Chan

Founder and Chairman

Chairman of PuraPharm Corporation Limited, Member of Advisory Committee of Government Chinese Medicines Testing Institute (GCMTI), Member of Pharmacy in Chinese Medicine Programmes Advisory Committee of Hong Kong Baptist University, and Member of School of Pharmacy Advisory Board of Chinese University of Hong Kong

Robert Miller

Chief Executive Officer

Founder and former CEO of Phynova, a UK life science company, the first company to receive UK regulatory approval to market a traditional Chinese medicine as an OTC drug. He has broad experience in the development and commercialisation of pharmaceuticals, OTC drugs and functional ingredients derived from medicinal plants

Sam Lum

Chief Financial Officer

A fellow member of HKICPA and FCCA UK, 20 years’ experience in corporate finance, merger and acquisition, and IPOs over 100 transactions of the listed companies. A preceding head of licensed corporate finance and asset management companies

Dr. James Li

Chief Scientific Officer

Former Assistant Professor of HKU in immunology and infectious diseases, Dr Li is a recipient of US$ 4 million for research of immunological diseases, infectious diseases and development of novel treatments and of awards from American Society for Virology, HK Society for Immunology, HKU/China Medical Board

Dr. Cindy Yang

Chief Research Officer

Principal inventor of 45 patents and former Research Officer of HKU with 15 years’ experience in natural product chemistry, inventions cover the treatments of various disease including Immunological Disease, Cancer, Neurological Disease and Infectious Disease

Stanley Chik

Chief Technical Officer

Expert in disease model development with 17 years’ experience in HKU as cell and molecular biologist, inventor of 24 patents in the field of herbal medicine applications in Immunological Disorders, Infectious Diseases and Oncology

Andrew Gallagher

Regulatory Affairs

Fifteen years’ experience in developing healthcare products from plants (Rx, OTC and functional ingredients). Experience covers full value chain, from discovery R&D, to clinical development, product registration and commercialization. Several publications relating to the development and registration of plant-based medicines. MSc Biological Sciences, MBA Finance

Dr. Wilfred Lin

Chief Data
Analytics Director

PhD, MACM, MIEEE, MIES, MAAAI, MIFIP (TC12 - Artificial Intelligence), HL7 (Health Level 7 Standard Associate Member) Co-founder, Chief Data Analytics Director, HerbMiners Informatics Limited. Over 20 years industrial experience in AI, Machine Learning, Data Mining, Knowledge Management, Quantum Cloud Computing project. Nine patents in USA, China, Hong Kong, Australia, Singapore, Europe, Germany, United Kingdom

Tyler Chan

Chief Operating Officer

Corporate Strategist at Purapharm Ltd with prior roles in Strategy Consulting, specializing in sell-side M&A deals as well as Integration & Separation Advisory. Extensive deal and operational strategy experience covering transactions across multiple industries, including healthcare, private equity, banking, insurance, consumer goods and energy